BC
NVRO

Bridgefront Capital’s NEVRO CORP. NVRO Stock Holding History

Bridgefront Capital’s Portfolio NVRO Stock Details NVRO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-10,662
Closed -$154K – 693
2024
Q1 		$154K Buy
+10,662
New +$176K 0.12% 334
2022
Q1 		– Sell
-2,623
Closed -$213K – 448
2021
Q4 		$213K Buy
+2,623
New +$263K 0.21% 229
2021
Q2 		– Sell
-1,993
Closed -$278K – 959
2021
Q1 		$278K Buy
+1,993
New +$325K 0.09% 455

Other funds holding NVRO

ACH
ArrowMark Colorado Holdings Denver, Colorado $3.76B AUM 21.77% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
FAM
Fred Alger Management New York $22.8B AUM 64.63% 1-Year Est. Return
EC
Engaged Capital Newport Beach, California $303M AUM 2.09% 1-Year Est. Return
B
Braidwell Stamford, Connecticut $3B AUM 46.72% 1-Year Est. Return
RSCM
Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Bridgefront Capital's NVRO Position: Q2 2024 in Review

Bridgefront Capital sold out of NEVRO CORP. (NVRO) in Q2 2024, closing a stake of 10,662 shares — an estimated $154K sold.

Bridgefront Capital first reported a position in NVRO in Q1 2021 and held it in 3 quarters. The position peaked at $278K in Q1 2021. 152 funds tracked by Wall St. Rank hold NVRO as of Q2 2024.

  • Bridgefront Capital reported no remaining NEVRO CORP. position as of Q2 2024 after selling out during the quarter.
  • Bridgefront Capital sold 10,662 NEVRO CORP. shares in Q2 2024, an estimated $154K.
  • Bridgefront Capital first reported a position in NEVRO CORP. in Q1 2021 and held it in 3 quarters.
  • Bridgefront Capital's NEVRO CORP. position peaked at $278K in Q1 2021.
  • 152 funds tracked by Wall St. Rank held NEVRO CORP. as of Q2 2024.

Based on Bridgefront Capital's 13F filing for Q2 2024, filed 14 Aug 2024.